Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-
Modify Date: 2024-01-01 22:55:38
![Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]- Structure](https://www.chemsrc.com/caspic/414/2414320-29-7.png)
Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]- structure
|
Common Name | Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]- | ||
|---|---|---|---|---|
| CAS Number | 2414320-29-7 | Molecular Weight | 436.43 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H19F3N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-MAGL-IN-6 is a potent MAGL inhibitor with an IC50 of 4.71 nM. MAGL-IN-6 can be used for neurological disorders research (WO2020065613A1; example 234)[1]. |
| Name | Methanone, 6-quinolinyl[(7S)-2,4,5,7-tetrahydro-2,7-dimethyl-3-(3,4,5-trifluorophenyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]- |
|---|
| Description | MAGL-IN-6 is a potent MAGL inhibitor with an IC50 of 4.71 nM. MAGL-IN-6 can be used for neurological disorders research (WO2020065613A1; example 234)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 4.71 nM (MAGL)[1] |
| References |
[1]. Michael K. Ameriks, et al. Monoacylglycerol lipase modulators. WO2020065613A1. |
| Molecular Formula | C24H19F3N4O |
|---|---|
| Molecular Weight | 436.43 |